Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Lymphoma 160Leukemia 109Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 85Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Mantle-Cell 70Leukemia, Myeloid, Acute 53Lymphoma, Follicular 49Hodgkin Disease 44Lymphoma, Large-Cell, Immunoblastic 37Leukemia, Lymphocytic, Chronic, B-Cell 33Recurrence 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 24Leukemia, Biphenotypic, Acute 24Myelodysplastic Syndromes 23Blast Crisis 19Lymphoma, Large-Cell, Anaplastic 18Lymphoma, B-Cell 18Dendritic Cell Sarcoma, Interdigitating 17Congenital Abnormalities 17Leukemia, Myeloid, Accelerated Phase 16Leukemia, Myelomonocytic, Chronic 15Multiple Myeloma 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, T-Cell 11Myeloproliferative Disorders 10Anemia, Refractory, with Excess of Blasts 10Neoplasms, Plasma Cell 9

Interventions

Cyclophosphamide 22fludarabine phosphate 19Whole-Body Irradiation 17Melphalan 16fludarabine 15Tacrolimus 14Busulfan 13Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Alemtuzumab 8Methotrexate 6Antilymphocyte Serum 6Cyclosporine 5thymoglobulin 4Thiotepa 3Stem Cell Transplantation 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3sargramostim 2Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × Cytarabine × Lymphoid × Clear all
NCT01500161 2013-11-25

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Texas Oncology Cancer Center

Phase 2 Terminated
1 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡